Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 4Phase 2/3 2Phase 1/2 2Phase NA 1Phase 1 1

Status

Completed 9Recruiting 2Not yet recruiting 2Active not recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1

Interventions

pembrolizumab 70Nivolumab 36Cyclophosphamide 34Carboplatin 28Dexamethasone 23Specimen Handling 22Paclitaxel 22Lenalidomide 22durvalumab 19Radiotherapy 19Gemcitabine 19venetoclax 18Magnetic Resonance Spectroscopy 18Doxorubicin 17Rituximab 16fludarabine 15Ipilimumab 15Bevacizumab 15Cisplatin 14Biopsy 14atezolizumab 13Etoposide 13Vincristine 12Pemetrexed 12belantamab mafodotin 11Docetaxel 11Calcium Dobesilate 11Azacitidine 11olaparib 10Oxaliplatin 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Active not recruiting × Prednisolone × Clear all
NCT02889523 2024-10-09

Epi-RCHOP

The Lymphoma Academic Research Organisation

Phase 1/2 Active not recruiting
214 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular

NCT04914741 2024-08-12

COALITION

Peter MacCallum Cancer Centre, Australia

Phase 1/2 Active not recruiting
80 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡